These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8794007)

  • 1. Immunology of papillomavirus infection.
    Frazer IH
    Curr Opin Immunol; 1996 Aug; 8(4):484-91. PubMed ID: 8794007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
    Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
    Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic aspects of infections with papillomaviruses. Prospects for a vaccine].
    Höpfl R; Heim K
    Hautarzt; 1996 Oct; 47(10):739-43. PubMed ID: 9036120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of the human papilloma virus in relation to cancer.
    Wu TC
    Curr Opin Immunol; 1994 Oct; 6(5):746-54. PubMed ID: 7826530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of human papillomavirus infection in lower genital tract neoplasia.
    Man S; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):701-14. PubMed ID: 11563868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunology of animal papillomaviruses.
    Nicholls PK; Stanley MA
    Vet Immunol Immunopathol; 2000 Feb; 73(2):101-27. PubMed ID: 10690928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
    Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
    Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of HPV infection and HPV-associated tumors.
    Majewski S; Jablonska S
    Int J Dermatol; 1998 Feb; 37(2):81-95. PubMed ID: 9542660
    [No Abstract]   [Full Text] [Related]  

  • 9. Papillomaviruses: a correlation between immune evasion and oncogenicity?
    O'Brien PM; Campo MS
    Trends Microbiol; 2003 Jul; 11(7):300-5. PubMed ID: 12875812
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation.
    Tindle RW; Frazer IH
    Curr Top Microbiol Immunol; 1994; 186():217-53. PubMed ID: 8205843
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential strategies utilised by papillomavirus to evade host immunity.
    Frazer IH; Thomas R; Zhou J; Leggatt GR; Dunn L; McMillan N; Tindle RW; Filgueira L; Manders P; Barnard P; Sharkey M
    Immunol Rev; 1999 Apr; 168():131-42. PubMed ID: 10399070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillomavirus virus-like particles as anticancer vaccines.
    Da Silva DM; Velders MP; Rudolf MP; Schiller JT; Kast WM
    Curr Opin Mol Ther; 1999 Feb; 1(1):82-8. PubMed ID: 11249689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to human papillomavirus-associated cervical neoplasia.
    Stern PL
    Adv Cancer Res; 1996; 69():175-211. PubMed ID: 8791682
    [No Abstract]   [Full Text] [Related]  

  • 14. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.
    Roden RB; Yutzy WH; Fallon R; Inglis S; Lowy DR; Schiller JT
    Virology; 2000 May; 270(2):254-7. PubMed ID: 10792983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response to human papillomavirus infection.
    Carter JJ; Galloway DA
    Clin Dermatol; 1997; 15(2):249-59. PubMed ID: 9167909
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunology of genital human papilloma virus infection.
    Stanley M
    Eur J Dermatol; 1998; 8(7 Suppl):8-12; discussion 20-2. PubMed ID: 10387957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillomavirus-like particles for serology and vaccine development.
    Kirnbauer R
    Intervirology; 1996; 39(1-2):54-61. PubMed ID: 8957670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16.
    Kowalczyk DW; Wlazlo AP; Shane S; Ertl HC
    Vaccine; 2001 May; 19(25-26):3583-90. PubMed ID: 11348726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune response to human papillomavirus infection.
    Scott M; Nakagawa M; Moscicki AB
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):209-20. PubMed ID: 11238198
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific human papillomaviruses could participate in epidermal hyperproliferation and autoimmune phenomena in psoriasis.
    Majewski S; Favre M; Orth G; Jablonska S
    Acta Derm Venereol; 2001; 81(4):312. PubMed ID: 11720190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.